C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 475/00 (2006.01)
Patent
CA 2570494
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, Bcr-abl, Bmx, c-RAF, CSK, Fes, FGFR3, Flt3, GSK3.beta. , IR, JNK1.alpha. 1, JNK2.alpha. 2, Lck, MKK4, MKK6, p70S6K, PDGFR.alpha. , Rsk1, SAPK2.alpha. , SAPK2.beta. , Syk and Trk.beta. kinases.
L'invention concerne une nouvelle catégorie de composés, des compositions pharmaceutiques les contenant, ainsi que des méthodes d'utilisation de ces composés dans le traitement ou la prévention de maladies ou de troubles associés à une activité kinase anormale ou déréglée, en particulier les maladies ou troubles impliquant l'activation anormale des kinases Abl, Bcr-abl, Bmx, c-RAF, CSK, Fes, FGFR3, Flt3, GSK3ß, IR, JNK1a1, JNK2a2, Lck, MKK4, MKK6, p70S6K, PDGFRa, Rsk1, SAPK2a, SAPK2ß, Syk et TrkB.
Gray Nathanael Schiander
Liu Yi
Ren Pingda
Sim Taebo
Wang Xia
Fetherstonhaugh & Co.
Irm Llc
LandOfFree
Pteridine derivatives as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pteridine derivatives as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pteridine derivatives as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1802031